Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages

Neurology

Volumn 46, Issue 6, 1996, Pages 1678-1683

  Privitera, M ^a   Fincham, R ^b   Penry, J ^c   Reife, R ^d   Kramer, L ^e   Pledger, G ^d   Karim, R ^d  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d R W JOHNSON PHARMACEUTICAL RES I   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPLOPIA; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EPILEPSY; FATIGUE; FEMALE; FOCAL EPILEPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

EID: 0029884747     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.6.1678     Document Type: Article

References (12)

1. Maryanoff BE, Margul BL. Topiramate. Drugs Future 1989; 14:342-344.
2. Wilder BJ, Penry JK, Rangel RJ, Riela A, Margul BL, Marriott TB. Topiramate: efficacy, toxicity, and dose/plasma concentrations [abstract]. Epilepsia 1988;29:698.
3. Rangel RJ, Penry JK, Wilder BJ, Riela A, Margul BL. Topiramate: a new antiepileptic drug for complex partial seizures - first use in epileptic patients [abstract]. Neurology 1988; 38(suppl 1):234.
4. Wilensky AJ, Ojemann LM, Chmelir T, Margul BL, Doose DR. Topiramate pharmacokinetics in epileptic patients receiving carbamazepine [abstract]. Epilepsia 1989;30:645-646.
5. Floren KL, Graves NM, Leppik IE, Remmel RP, Margul BL, Doose DR. Pharmacokinetics of topiramate in patients with partial epilepsy receiving phenytoin or valproate [abstract]. Epilepsia 1989;30:646.
6. Conover WJ, Iman RL. Rank transformation as a bridge between parametric and nonparametric statistics. Am Stat 1981; 35:124-133.
7. Hollander M, Wolfe DA. Nonparametric statistical methods. New York: John Wiley & Sons, 1973.
8. Lehmann EL. Nonparametrics: statistics based on ranks. San Francisco: Holden Day, 1975.
9. Loiseau P. Intractable epilepsy: prognostic evaluation. In: Schmidt D, Morselli PL, eds. Intractable epilepsy: experimental and clinical aspects. New York: Raven Press, 1986.
10. US Gabapentin Study Group No. 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel group study. Neurology 1993;43:2292-2298.
11. Matsuo F, Bergen D, Faught E, et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993;43:2284-2291.
12. Kramer LD, Pledger GW, Kamin M. Prototype antiepileptic drug clinical development plan. Epilepsia 1993;34:1075-1084.